BIA Brexit Readiness Webinar - 11 October

This webinar is part of a series of BIA Brexit Briefings that provide updates for our UK and International audiences answering 'What does Brexit mean for Biotechnology in the UK and beyond? 

To provide additional support to the sector the BIA will be running "Brexit Readiness" webinars in the lead up to 31st October.

These webinars start on 27th September and are then running: 4th October, 11th October, and 29th October.

Following the outcome of the UK’s referendum on membership of the European Union, the BIA has worked closely with members and stakeholders to identify the threats and opportunities for biotech post-Brexit and to represent the sector.

Our BIA Brexit Briefing webinars provide updates on Government policy, progress of working groups, and how these potentially affect companies in life sciences. 

Speakers

Steve Bates

Chief Executive Officer

BIA

Since his appointment as Chief Executive of the BioIndustry Association in 2012, Steve has led major BIA campaigns for, amongst other things, improved access to finance, the refilling of the Biomedical Catalyst, anti-microbial resistance and the opportunity the sector presents to generalist long term investors. Steve champions the adaptive pathway approach to the licensing of new drugs, the need for Early Access and is particularly proud of the working relationship the BIA has established with the UK’s leading medical research charities.

A founder member of United Life Sciences, a strategic partnership representing over 1000 life science and healthcare member companies across the UK and internationally, Steve attends the UK’s Ministerial Industry Strategy Group, and sits on The Royal Society's Science, Industry and Translation Committee.

Beyond the UK Steve is a member of EuropaBio’s Board and its National Association Council and is a founder member of the International Confederation of Biotech Associations. An expert and regular commentator on the sector in the media and at industry-leading conferences Steve has worked both in biotech (as Senior Director at Genzyme UK and Ireland) and at the highest levels of UK government (as Special Advisor to John Reid, MP, during his time in Tony Blair’s government) for over 15 years. Steve was awarded the OBE in January 2017.

Tim Sarson

Partner, Brexit and Value Chain Management

KPMG UK

In the last decade a particular focus of Tim’s has been on developing an integrated tax, commercial and operational approach to transformation projects. He has a particular focus on geography and location, helping companies to adapt to changes in the global landscape of tax, labour, trading flows and geopolitics

Tim is currently advising a number of clients on the impacts of Brexit, working with a wide range of KPMG specialists in supply chain, regulation, customs, immigration, legal services and political intelligence.


 

Cost

Free for members and non-members

 

By registering to this event you accept our Terms & Conditions

 

BIA Annual Supporters